50-172-6509

TPMT Rabbit anti-Human, Mouse, Rat, Polyclonal, Proteintech

Manufacturer: Proteintech Group Inc

Select a Size

Pack Size SKU Availability Price
Each of 1 50-172-6509-Each-of-1 In Stock ₹ 44,150.23

50-172-6509 - Each of 1

₹ 44,150.23

In Stock

Quantity

1

Base Price: ₹ 44,150.23

GST (18%): ₹ 7,947.041

Total Price: ₹ 52,097.271

Antigen

TPMT

Classification

Polyclonal

Conjugate

Unconjugated

Gene

TPMT

Gene Alias

Thiopurine methyltransferase, thiopurine S methyltransferase, TPMT

Host Species

Rabbit

Purification Method

Antigen Affinity Chromatography

Regulatory Status

RUO

Gene ID (Entrez)

22017, 690050, 7172

Content And Storage

-20°C

Form

Liquid

Applications

Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot

Concentration

0.15 mg/mL

Formulation

PBS with 50% glycerol and 0.1% sodium azide; pH 7.3

Gene Accession No.

O55060, P51580, Q9Z0T0

Gene Symbols

TPMT

Immunogen

TPMT Fusion Protein Ag1074

Quantity

150 μL

Primary or Secondary

Primary

Target Species

Human, Mouse, Rat

Product Type

Antibody

Isotype

IgG

Related Products

Img

Proteintech Group Inc

50-172-6820

--

Img

Proteintech Group Inc

50-173-0264

--

Img

Proteintech Group Inc

50-173-0837

--

Img

Proteintech Group Inc

50-173-3999

--

Img

Proteintech Group Inc

50-172-9709

--

Img

Proteintech Group Inc

50-172-9829

--

Img

Proteintech Group Inc

50-173-3496

--

Img

Proteintech Group Inc

50-172-9837

--

Description

  • This antibody specifically recognizes the 34 kDa protein
  • Catalyzes the S-methylation of thiopurine drugs such as 6-mercaptopurine
  • Defects in TPMT are the cause of thiopurine S-methyltransferase deficiency (TPMT deficiency)
  • TPMT is an enzyme involved in the normal metabolic inactivation of thiopurine drugs
  • These drugs are generally used as immunosupressants or cytotoxic drugs and are prescribed for a variety of clinical conditions including leukemia, autoimmune disease and organ transplantation
  • Patients with intermediate or no TPMT activity are at risk of toxicity after receiving standard doses of thiopurine drugs and it is shown that inter-individual differences in response to these drugs are largely determined by genetic variation at the TPMT locus.